K. Hoel et A. Lillehaug, ADJUVANT ACTIVITY OF POLAR GLYCOPEPTIDOLIPIDS FROM MYCOBACTERIUM-CHELONAE IN EXPERIMENTAL VACCINES AGAINST AEROMONAS-SALMONICIDA IN SALMONID FISH, Fish & shellfish immunology, 7(6), 1997, pp. 365-376
In order to evaluate the adjuvant activity in fish of polar glycopepti
dolipids from Mycobacterium chelonae (pGPL-Mc), salmonids were injecte
d with pGPL-Mc alone or in combination with Aeromonas salmonicida bact
erin. Side-effects, antibody production against A. salmonicida and lym
phocyte stimulation were studied. Twelve weeks after vaccination, the
antibody responses of fish injected with 0.25 mg kg(-1) pGPL-Mc in add
ition to bacterial antigen were significantly stronger than those in f
ish injected with a non-adjuvanted bacterin, and insignificantly lower
than the antibody titles achieved with an oil-adjuvanted reference va
ccine. Higher doses of pGPL-Mc reduced the levels of specific antibodi
es. The lymphocyte responses to lipopolysaccharide (LPS), a potent B-c
ell mitogen, were higher in rainbow trout injected with pGPL-Mc alone,
compared to the fish injected with saline, suggesting B-cell activati
on as a mechanism. pCPL-Mc showed a weak dose-dependent mitogen effect
on fish leucocytes. No significant side-effects were observed after i
ntraperitoneal injection of pGPL-Mc. The relatively long-term immunost
imulation in fish with no side-effects makes pGPL-Mc an interesting ca
ndidate adjuvant for incorporation in future vaccine formulations. (C)
1997 Academic Press Limited.